Patent ID: 7112612

Claim:
A method for treating epilepsy, migraine, bipolar disorders, chronic pain or neuropathic pain in a mammal in need of such treatment, comprising administering a therapeutic dose of at least one compound according to formula (I) including geometrical isomers, enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts or prodrugs thereof, wherein: R 0 is selected from the group consisting of —OR 1 , —SR 1 or —NR 2 R 1 ; R 1 and R 2 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, heterocycle, aryl, arylalkyl, acyl derivatives, imidoyl, amido, ester, oxo and -(L 1 )-R 3 or together are -L 2 -; if R 0 is —NR 2 R 1 then R 1 may also be oxy derivatives or amino derivatives; R 3 is selected from the group consisting of cycloalkyl, cycloalkenyl, heterocycle, aryl, oxy derivatives, thio derivatives, amino derivatives, acyl derivatives, acyloxy derivatives, ether, imidoyl, amido, amidooxy, ester, esteroxy, sulfinyl, sulfonyl; L 1 is a straight or branched alkylene, alkenylene, alkynylene; L 2 is a straight or branched alkylene, alkenylene, alkynylene, or one of the foregoing in which one or more methylenes are replaced by —O—, —S— or —NH—.